Jim Cramer - Mad Money
American Well
AMWL-N
DON'T BUY
Nov 16, 2020
A telehealth that IPOd earlier this year. That had a recent bad quarter with disappointing earnings. They're in the penalty box and he doesn't want to be there.
2020 IPOs cost too much, and are worth buying now that they are out of style and cheaper. A telemedicine stock which had a phenomenal run during Covid. With the reopening now in full swing, this stock has lost two-thirds. Even at the current $17, avoid, because this is too much a lockdown stock. Avoid.
Your Watchlist
Add stocks to watchlist to monitor them daily and get important alerts.